Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01717131

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

A Non Inferiority Randomized Multicenter Phase III Trial of Axillary Node Dissection Versus no Axillary Node Dissection in Case of Positive Sentinel Lymph Node in Invasive Breast Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,228 (actual)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Data from cohorts, prospective studies and one randomized trial (ASCOG Z0011) support the hypothesis that omission of additional axillary dissection in case of positive sentinel node has a limited impact on overall survival and relapse free survival. However, these data are not sufficient enough to recommend, as a standard of care, to avoid axillary dissection in case of positive sentinel node. The ASCOG Z0011 trial has been closed before the end of inclusions and the predefined non inferiority margin was found to be too large (5% difference at 5 years for primary endpoint). Prospective randomized trial is then urgently mandatory before omission of axillary node dissection becomes a usual practice without a sufficient scientific level of proof. Indeed, in several reviews, the rate of omission of axillary node dissection in case of micrometastasis increased (Bilimoria) despite any strong proof has been demonstrated. The omission of axillary node dissection in case of positive sentinel node may have strong practical impacts on patients but also on medical and economical aspects: in avoiding a prolonged hospitalisation, secondary morbidities due to axillary dissection requiring secondary care and their costs, as well as costs for secondary axillary dissection (14 to 25% in case of positive sentinel node) and finally shortening surgery duration. The main investigator propose a Non Inferiority Randomized Multicenter Phase III Trial of Axillary Node Dissection Versus no Axillary Node Dissection in Case of Positive Sentinel Lymph Node in Invasive Breast Cancer

Conditions

Interventions

TypeNameDescription
PROCEDURESurgery for standard axillary node dissection
OTHERNo axillary lymph node dissectionNo surgery on axillary lymph node

Timeline

Start date
2012-07-19
Primary completion
2021-09-01
Completion
2031-09-01
First posted
2012-10-30
Last updated
2024-01-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01717131. Inclusion in this directory is not an endorsement.